Evidence map›Paper›PMID 34622527›Full record

ArticleEuropean journal of pain (London, England)2022

Insight into pain syndromes in acute phase of mild-to-moderate COVID-19: Frequency, clinical characteristics, and associated factors.

Emel Oguz-Akarsu, Gizem Gullu, Erhan Kilic, Yasemin Dinç, Ahmet Ursavas, Emel Yilmaz, Mehmet Zarifoglu, Necdet Karli, Pandemic Study Team

Open access · bronzeAbstract read
In one paragraph

Article in European journal of pain (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Beyond the acute: pain in long COVID survivors at 1.5 years.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Article
  6. Article
  7. Pain types and risk factors in post-COVID-19.Turkish journal of physical medicine and rehabilitation · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Neuropathic pain in patients with post-COVID-19.Northern clinics of Istanbul · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Emel Oguz-AkarsuDepartment of Neurology, Uludag School of Medicine, Uludag University, Bursa, Turkey.ORCID 0000-0002-0465-4218
Gizem GulluDepartment of Neurology, Uludag School of Medicine, Uludag University, Bursa, Turkey.
Erhan KilicDepartment of Neurology, Uludag School of Medicine, Uludag University, Bursa, Turkey.
Yasemin DinçDepartment of Neurology, Uludag School of Medicine, Uludag University, Bursa, Turkey.
Ahmet UrsavasDepartment of Chest Diseases, Uludag School of Medicine, Uludag University, Bursa, Turkey.
Emel YilmazDepartment of Infectious Disease, Uludag School of Medicine, Uludag University, Bursa, Turkey.
Mehmet ZarifogluDepartment of Neurology, Uludag School of Medicine, Uludag University, Bursa, Turkey.
Necdet KarliDepartment of Neurology, Uludag School of Medicine, Uludag University, Bursa, Turkey.
Pandemic Study Team
Bursa Uludağ Üni̇versi̇tesi̇ · TRApple (Israel) · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPain has been frequently described as a clinical feature of COVID-19, and the main pain syndromes that have been associated with the acute phase of this disease so far are headache, myalgia, arthralgia, and neuropathic pain. Understanding the characteristics of pain symptoms is crucial for a better clinical approach.

methodsPatients who were diagnosed as having COVID-19 using reverse transcription-polymerase chain reaction were included in the study. Patients were asked to complete a 51-item questionnaire via a phone interview, which included questions on demographics, acute COVID-19 symptoms, the presence of pain symptoms, and their characteristics in the acute phase of COVID-19.

resultsA total of 222 out of 266 patients with COVID-19 participated in the study, yielding a response rate of 83.5%. A total of 159 patients reported at least one kind of pain syndrome with a prevalence of 71.6%. Myalgia was reported in 110 (49.6%) patients, headache in 109 (49.1%), neuropathic pain symptoms in 55 (24.8%), and polyarthralgia in 30 (13.5%) patients. A total of 66 patients reported only one type of pain, 46 reported two types, 42 reported three types, and five patients reported all four types of pain. Logistic regression analysis showed that there were significant associations between these pain syndromes and a strong association was found between neuropathic pain and headache.

conclusionPain is a frequently observed symptom of mild-to-moderate COVID-19. There are significant relationships between pain syndromes in COVID-19, which may be due to a sequence of common etiologic factors. SIGNIFICANCE: This study described the main pain syndromes associated acute phase of mild-to-moderate COVID-19 and its associated features. Headaches and pain of neuropathic characteristics were prevalent in this sample.

Indexed as

COVID-19HeadacheHumansMyalgiaSARS-CoV-2Syndrome

Identifiers

PMID34622527
PMCPMC8653127
OpenAlexW3204834917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.